Model-based estimation of the impact on rotavirus disease of RV3-BB vaccine administered in a neonatal or infant schedule

Nicholas Gearda School of Computing and Information Systems, The University of Melbourne, Parkville, AustraliaCorrespondence[email protected]

https://orcid.org/0000-0003-0069-2281 View further author information

Richard Bradhurstb Centre of Excellence for Biosecurity Risk Analysis, School of BioSciences, The University of Melbourne, Parkville, AustraliaView further author information

Nefel Tellioglua School of Computing and Information Systems, The University of Melbourne, Parkville, AustraliaView further author information

Vicka Oktariac Department of Biostatistics, Epidemiology, and Population Health, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta, Indonesia;d Center for Child Health – Pediatric Research Office, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta, IndonesiaView further author information

Jodie McVernone Department of Infectious Diseases and Victorian Infectious Diseases Reference Laboratory Epidemiology Unit, The Peter Doherty Institute for Infection and Immunity, The Royal Melbourne Hospital and The University of Melbourne, Parkville, Australia;f Melbourne School of Population and Global Health, The University of Melbourne, Parkville, Australia;g Murdoch Children’s Research Institute, Parkville, AustraliaView further author information

Amanda Handleyg Murdoch Children’s Research Institute, Parkville, Australia;h Medicines Development for Global Health, Southbank, AustraliaView further author information

Julie E. Binesg Murdoch Children’s Research Institute, Parkville, Australia;i Department of Gastroenterology and Clinical Nutrition, Royal Children’s Hospital, Parkville, Australia;j Department of Paediatrics, The University of Melbourne, Parkville, AustraliaView further author information

show all

Model-based estimation of the impact on rotavirus disease of RV3-BB vaccine administered in a neonatal or infant schedule

Supplemental Figures and Tables

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Model-based estimation of the impact on rotavirus disease of RV3-BB vaccine administered in a neonatal or infant schedule

Supplemental Figures and Tables

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date